Clinician’s Day took place on Sunday, October 11, 2015 during the 2015 International Summit on Suicide Research.

A maximum of 5.5 continuing education hours credits were offered for Sunday’s program.

 

Click on the below hyper-linked titles to view PDFs of the Clinician’s Day presentations.

Suicide Prevention: Setting the Stage – Christine Moutier

Suicide Risk Assessment: State of the Art – Jill Harkavy-Friedman

Managing Suicidal Patients in Outpatient Settings: Strategies to Safely Avoid  Hospitalization– David Jobes

Psychotherapeutic Approaches with Suicidal Patients – Lars Mehlum

Neurobiology of Suicide and Pharmacological Approaches – John Mann

Neurobiology of Suicide and Pharmacological Approaches– John Walkup

Managing Medicolegal Risk When Treating Suicidal Patients – Lanny Berman

Clinician’s Day Program, Sunday, October 11, 2015

8:00 AM – 8:15 AM Welcome and Opening Remarks AFSP and Lynn Keane
8:15 AM – 8:45 AM Suicide Prevention: Setting the Stage Christine Moutier
8:45 AM – 9:45 AM Suicide Risk Assessment: State of the Art Jill Harkavy- Friedman
9:45 AM – 10:00 AM BREAK
10:00 AM – 11:00 AM Managing Suicidal Patients in Outpatient Settings: Strategies to Safely Avoid  Hospitalization David Jobes
11:00 AM- 12:00 PM Psychotherapeutic Approaches with Suicidal Patients Greg Brown and Lars Mehlum
12:00 PM – 1:00 PM Lunch On Own
1:00 PM – 2:00 PM Neurobiology of Suicide and Pharmacological Approaches John Mann and John Walkup
2:00 PM – 2:45 PM Managing Medicolegal Risk When Treating Suicidal Patients Lanny Berman
 2:45 PM  Wrap Up

 

Clinician’s Day Learning Objectives:

At the conclusion of the event, participants will be able to:

1. Articulate the risk factors and warning signs for suicide

2. Describe several short-term management strategies for patients experiencing suicidal ideation or behavior

3. Enumerate several available evidence-based strategies for treating the suicidal individual

4. Discuss the key medical legal issues and recommend strategies for mitigating risk in working with suicidal patients